On Thursday, Shares of Chevron Corporation (NYSE:CVX), subtract -1.33% and closed at $100.79 in the last trading session. The last trading range of the stock ranges between $99.61 and $101.72. Chevron U.S.A. Inc. ( NYSE : CVX ) declared recently the launch of its aFANity™ Rewards Program, a sports-themed rewards program available to residents of Alabama, Arizona, California, Florida, Georgia, Idaho, Louisiana, Mississippi, Nevada, New Mexico, Oregon, Tennessee, Texas, Utah, Washington and Wyoming. Eligible participants can sign up as members to begin earning points starting on October 1. They can redeem those points for prizes such as football tickets, autographed memorabilia, officially licensed team gear, and unique once-in-a-lifetime experiences with their favorite teams.
Sports fans will have a chance to reward themselves with exciting gear and memorabilia that fit their passion. Members earn points just for signing up with aFANity™ and can earn additional points through activities, like connecting their social media accounts, connecting their Chevron and Texaco Techron Advantage™ Credit Card, using their connected card at Chevron and Texaco stations in the participating areas, and even attending Chevron-sponsored football games.
“Sports fans are extremely passionate individuals, so we wanted to tap into that enthusiasm and find a way to reward them,” said Don Walker, General Manager of Chevron Brand. “Being able to offer once-in-a-lifetime experiences with teams and other rewards such as autographed memorabilia will allow us to connect with consumers in a way we never have before.”
Xcel Energy Inc (NYSE:XEL), jumped 1.56% and closed at $40.34 in the last trading session. The last trading range of the stock ranges between $39.72 and $40.62. The company’s Market capitalization is $20.63 Billion with the total outstanding Shares of 507.95 million. On Thursday, October 27, 2016, Xcel Energy (XEL) will host a conference call to review third quarter financial results. Earnings will be released before the opening of trading.
The call will begin at 9:00 a.m. Central Time. To take part in the conference call, please dial in at least 5-10 minutes before the planned start and follow the operator’s instructions. You will be asked for the conference ID number.
US Dial-In: 888-455-2311
International Dial-In: 719-325-2474
Conference ID: 5131866
Tokai Pharmaceuticals Inc (NASDAQ:TKAI), jumped 1.39% and closed at $1.82 in the last trading session. The last trading range of the stock ranges between $1.56 and $1.86. During the 52-week trading session the minimum price at which share price traded, registered at $0.98 and reached to max level of $12.93. Tokai Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for prostate cancer and other hormonally-driven diseases. Its lead drug candidate is galeterone, an oral small molecule that is in various clinical trials for the treatment of patients with metastatic castration-resistant prostate cancer. The companys androgen receptor degradation (ARDA) drug discovery program is focused on identifying and developing compounds for ARDA activity.